Suppr超能文献

人隐静脉的体外搏动灌注可诱导内膜增生并使纤溶酶原激活物抑制剂1水平升高。

Ex vivo pulsatile perfusion of human saphenous veins induces intimal hyperplasia and increased levels of the plasminogen activator inhibitor 1.

作者信息

Saucy F, Probst H, Alonso F, Bérard X, Déglise S, Dunoyer-Geindre S, Mazzolai L, Kruithof E, Haefliger J-A, Corpataux J-M

机构信息

Division of Thoracic and Vascular Surgery, CHUV, Lausanne, Switzerland. Francois.Saucy @ chuv.ch

出版信息

Eur Surg Res. 2010;45(1):50-9. doi: 10.1159/000318602. Epub 2010 Aug 28.

Abstract

Vessel wall trauma induces vascular remodeling processes including the development of intimal hyperplasia (IH). To assess the development of IH in human veins, we have used an ex vivo vein support system (EVVSS) allowing the perfusion of freshly isolated segments of saphenous veins in the presence of a pulsatile flow which reproduced arterial conditions regarding shear stress, flow rate and pressure during a period of 7 and 14 days. Compared to the corresponding freshly harvested human veins, histomorphometric analysis showed a significant increase in the intimal thickness which was already maximal after 7 days of perfusion. Expression of the endothelial marker CD31 demonstrated the presence of endothelium up to 14 days of perfusion. In our EVVSS model, the activity as well as the mRNA and protein expression levels of plasminogen activator inhibitor 1, the inhibitor of urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA), were increased after 7 days of perfusion, whereas the expression levels of tPA and uPA were not altered. No major change was observed between 7 and 14 days of perfusion. These data show that our newly developed EVVSS is a valuable setting to study ex vivo remodeling of human veins submitted to a pulsatile flow.

摘要

血管壁损伤会引发血管重塑过程,包括内膜增生(IH)的发展。为了评估人类静脉中IH的发展情况,我们使用了一种离体静脉支持系统(EVVSS),该系统能够在脉动流存在的情况下对新鲜分离的大隐静脉段进行灌注,这种脉动流在7天和14天的时间内再现了关于剪切应力、流速和压力的动脉条件。与相应的新鲜采集的人类静脉相比,组织形态计量学分析显示内膜厚度显著增加,在灌注7天后已达到最大值。内皮标志物CD31的表达表明在灌注长达14天的时间内内皮细胞一直存在。在我们的EVVSS模型中,灌注7天后,纤溶酶原激活物抑制剂1(尿激酶型纤溶酶原激活物(uPA)和组织型纤溶酶原激活物(tPA)的抑制剂)的活性以及mRNA和蛋白质表达水平均升高,而tPA和uPA的表达水平未发生改变。在灌注7天和14天之间未观察到重大变化。这些数据表明,我们新开发的EVVSS是研究经受脉动流的人类静脉离体重塑的有价值的实验环境。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验